2022
Overnight Abstinence Is Associated With Smaller Secondary Somatosensory Cortical Volumes and Higher Somatosensory-Motor Cortical Functional Connectivity in Cigarette Smokers
Chen Y, Dhingra I, Chaudhary S, Fucito L, Li CR. Overnight Abstinence Is Associated With Smaller Secondary Somatosensory Cortical Volumes and Higher Somatosensory-Motor Cortical Functional Connectivity in Cigarette Smokers. Nicotine & Tobacco Research 2022, 24: 1889-1897. PMID: 35796689, PMCID: PMC9653081, DOI: 10.1093/ntr/ntac168.Peer-Reviewed Original ResearchMeSH KeywordsHumansMagnetic Resonance ImagingNicotineSmokersSomatosensory CortexSubstance Withdrawal SyndromeTobacco ProductsConceptsResting-state functional connectivityGray matter volumeWithdrawal symptom severityOvernight abstinenceFunctional connectivityRight SIISymptom severityCigarette smokersSomatosensory cortexMatter volumeRight secondary somatosensory cortexSmaller gray matter volumeSubcortical gray matter volumesSecond somatosensory cortexSecondary somatosensory cortexCortical functional connectivityMotor impulsivityVoxel-wise morphometryRegional gray matter volumeLeft ventral hippocampusGMV alterationsCigarette smokingSatiety stateAbstinence symptomsHigher-order sensory corticesExamining Tobacco Treatment Perceptions and Barriers Among Black vs. Non-Black Adults Attending Lung Cancer Screening
Bold KW, Cannon S, Ford BB, Neveu S, Sather P, Toll BA, Fucito LM. Examining Tobacco Treatment Perceptions and Barriers Among Black vs. Non-Black Adults Attending Lung Cancer Screening. Cancer Prevention Research 2022, 15: 327-333. PMID: 35063942, PMCID: PMC9064926, DOI: 10.1158/1940-6207.capr-21-0398.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedEarly Detection of CancerFemaleHumansLung NeoplasmsMaleMiddle AgedSubstance Withdrawal SyndromeTobaccoTobacco ProductsConceptsLung cancer screeningCancer screeningTobacco treatmentWithdrawal symptomsRace/ethnicityTreatment perceptionsUS Preventive Services Task ForceHealth disparitiesAnnual lung cancerSmilow Cancer HospitalYale-New HavenCharacteristics of patientsHigh-risk patientsHigh-risk populationNon-Hispanic blacksTobacco-related health disparitiesAddress health disparitiesPatient characteristicsSmoking historyBlack patientsCancer HospitalLung cancerHigh riskPatientsSmoking
2015
How Imaging Glutamate, γ‐Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and Withdrawal
Hillmer AT, Mason GF, Fucito LM, O'Malley SS, Cosgrove KP. How Imaging Glutamate, γ‐Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and Withdrawal. Alcohol Clinical And Experimental Research 2015, 39: 2268-2282. PMID: 26510169, PMCID: PMC4712074, DOI: 10.1111/acer.12893.Peer-Reviewed Original ResearchMeSH KeywordsAlcoholismCross-Sectional StudiesDopamineGamma-Aminobutyric AcidGlutamic AcidHumansNeuroimagingSubstance Withdrawal SyndromeTreatment OutcomeConceptsAlcohol dependenceΓ-aminobutyric acidClinical treatmentMajor public health issuePublic health issuePositron emission tomographyRelapse prevention strategiesSingle photon emissionSpecific imaging modalityAlcohol withdrawalTobacco smokingGABA systemNeurotransmitter systemsNeurochemical basisPrevention strategiesDopaminergic functioningEmission tomographyHealth issuesImaging modalitiesWithdrawalSex differencesImaging literatureDopamineTomographyGlutamate